Literature DB >> 2819943

Hepatic arterial flow distribution with hepatic neoplasms: significance in infusion chemotherapy.

C Charnsangavej, C H Carrasco, S Wallace, W Richli, T P Haynie.   

Abstract

Hepatic artery radionuclide flow studies and hepatic angiography in eight patients with various hepatic neoplasms were evaluated to determine the patterns of arterial flow distribution in the presence of portal vein occlusion. Increased hepatic arterial blood flow to the lobe or segment supplied by the occluded portal vein was observed in all patients. This phenomenon must be taken into account when positioning catheters for hepatic artery infusion chemotherapy; while it may improve the flow of chemotherapeutic agents to tumors located in the area of an occluded portal vein branch, it may also result in diversion of flow to the normal hepatic parenchyma away from tumors occupying the hepatic segments with patent portal venous flow. Hepatic angiography and radionuclide flow studies provide the necessary information for correct positioning of hepatic artery infusion catheters.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2819943     DOI: 10.1148/radiology.165.1.2819943

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  3 in total

1.  Low infusion rate digital subtraction angiography to predict regional perfusion in hepatic arterial chemotherapy.

Authors:  J C Andrews; D M Williams; B Shapiro; W D Ensminger
Journal:  Cardiovasc Intervent Radiol       Date:  1989 Sep-Oct       Impact factor: 2.740

2.  Anatomic and technical skill factor of gastroduodenal complication in post-transarterial embolization for hepatocellular carcinoma: a retrospective study of 280 cases.

Authors:  Ting-Kai Leung; Chi-Ming Lee; Hsin-Chi Chen
Journal:  World J Gastroenterol       Date:  2005-03-14       Impact factor: 5.742

3.  Intra-arterial infusion of N-isopropyl-p[123I]iodoamphetamine for assessing effective blood supply to pulmonary and hepatic neoplasms.

Authors:  C Miyazaki
Journal:  Ann Nucl Med       Date:  1994-05       Impact factor: 2.668

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.